Press Releases

TxCell SA, a biotechnology company developing cell-based immunotherapies for the treatment of severe chronic inflammatory diseases with high unmet medical need, announces today the publication of the complete results of CATS1 Crohn’s disease study in Gastroenterology, the most...

Cytheris SA, a clinical-stage biopharmaceutical company focused on treating lymphopenia driven diseases, announces today that the US Food and Drug Administration (FDA) has granted an Orphan Drug Designation for Cytheris’ CYT017, glycosylated recombinant human interleukin-7 (glycosylated r-h-IL7), for the...

Domain Therapeutics S.A. announced today that Domain Therapeutics and Ono Pharmaceutical Co., Ltd. (Osaka, Japan) signed a collaboration agreement focused on discovering small molecules targeting G-Protein Coupled Receptors (GPCRs).  Under the agreement, Ono will...

Adocia , a biotech company specialized in the formulation of therapeutic proteins for the treatment of diabetes and chronic wounds, announces today that it has filed another three patent applications covering new formulations of monoclonal antibodies.  ...

Genzyme, a Sanofi company , and Isis Pharmaceuticals Inc. , announced today that the Endocrinologic and Metabolic Drugs Advisory Committee of the U.S. Food and Drug Administration (FDA) voted 9 to 6 that Genzyme had provided sufficient efficacy...

NPS Pharmaceuticals, Inc. , a biopharmaceutical company developing innovative therapeutics for rare gastrointestinal and endocrine disorders, announced today that the U.S. Food and Drug Administration’s (FDA) Gastrointestinal Drugs Advisory Committee voted unanimously to recommend approval of Gattex® (teduglutide)...

Vince & Associates Clinical Research announced today that it provided platinum sponsorship of the 6th Annual Pain Therapeutics Summit held October 3-4, 2012, in San Jose, Calif. The conference convened multidisciplinary industry colleagues to discuss...